Genetics of obesity and obesity-related hypertension

被引:9
|
作者
Hamann, A
Sharma, AM
机构
[1] Univ Heidelberg, Dept Internal Med, D-6900 Heidelberg, Germany
[2] Humboldt Univ, Franz Volhard Clin, Charite, D-1086 Berlin, Germany
[3] Max Delbruck Ctr Mol Med, Berlin, Germany
关键词
D O I
10.1053/snep.2002.30208
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Obesity results from an imbalance between caloric intake and energy expenditure. Twin, adoption, and family studies have not only shown that genetic factors play an important role in the pathogenesis of obesity, but also contribute to several comorbidities including hypertension and type 2 diabetes. In recent years, several single-gene defects responsible for obesity in rodents and, in rare cases, of human obesity have been identified. Besides leptin as the most notable example, numerous other proteins and neuropeptides have recently been found that participate in a complex network to regulate food intake and energy expenditure. Interestingly, some of these molecules may also play a role in the development of obesity-related hypertension. The ongoing search for relevant genetic variants should result in a better understanding of energy metabolism and hopefully clarify molecular mechanisms underlying the association between obesity and related comorbidities. This knowledge should help develop new strategies for the treatment of obesity and associated risk factors for hypertension and related cardiovascular disorders.
引用
收藏
页码:100 / 104
页数:5
相关论文
共 50 条
  • [31] Neural mechanisms and management of obesity-related hypertension
    Esler M.D.
    Eikelis N.
    Lambert E.
    Straznicky N.
    Current Cardiology Reports, 2008, 10 (6) : 456 - 463
  • [32] Cardiac transcriptome analysis in obesity-related hypertension
    Philip-Couderc, P
    Smih, F
    Pelat, M
    Vidal, C
    Verwaerde, P
    Pathak, A
    Buys, S
    Galinier, M
    Senard, JM
    Rouet, P
    HYPERTENSION, 2003, 41 (03) : 414 - 421
  • [33] Optimal treatment of obesity-related hypertension - The Hypertension-Obesity-Sibutramine (HOS) Study
    Scholze, Juergen
    Grimm, Elmar
    Herrmann, Dana
    Unger, Thomas
    Kintscher, Ulrich
    CIRCULATION, 2007, 115 (15) : 1991 - 1998
  • [34] Adiponectin replenishment ameliorates obesity-related hypertension
    Ohashi, Koji
    Kihara, Shinji
    Ouchi, Noriyuki
    Kumada, Masahiro
    Fujita, Koichi
    Hiuge, Aki
    Hibuse, Toshiyuki
    Ryo, Miwa
    Nishizawa, Hitoshi
    Maeda, Norikazu
    Maeda, Kazuhisa
    Shibata, Rei
    Walsh, Kenneth
    Funahashi, Tohru
    Shimomura, Iichiro
    HYPERTENSION, 2006, 47 (06) : 1108 - 1116
  • [35] Recent developments in the treatment of obesity-related hypertension
    Pischon, T
    Sharma, AM
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2002, 11 (05): : 497 - 502
  • [36] Treatment of Obesity-Related Hypertension in Children and Adolescents
    Susan M. Halbach
    Joseph Flynn
    Current Hypertension Reports, 2013, 15 : 224 - 231
  • [37] Hydralazine as antihypertensive therapy in obesity-related hypertension
    J F Carroll
    J W King
    J S Cohen
    International Journal of Obesity, 2004, 28 : 384 - 390
  • [38] Effect of diabetes and hypertension on obesity-related mortality
    Livingston, EH
    Ko, CY
    SURGERY, 2005, 137 (01) : 16 - 25
  • [39] Highlights of mechanisms and treatment of obesity-related hypertension
    Shams, Elham
    Kamalumpundi, Vijayvardhan
    Peterson, Joshua
    Gismondi, Ronaldo Altenburg
    Oigman, Wille
    de Gusmao Correia, Marcelo Lima
    JOURNAL OF HUMAN HYPERTENSION, 2022, 36 (09) : 785 - 793
  • [40] THE ZUCKER RAT AS A MODEL OF OBESITY-RELATED HYPERTENSION
    KURTZ, TW
    MORRIS, RC
    PERSHADSINGH, HA
    HYPERTENSION, 1988, 12 (03) : 354 - 354